TerrAscend's Revenue More Than Doubles Quarter-Over-Quarter
Terrascend Corp (OTC:TRSSF) reported first-quarter revenue of CA$14.6 million ($10.8 million) Thursday and reiterated its full-year guidance.
The cannabis company said its revenue surged higher from CA$5 million in the fourth quarter.
TerraAscend had zero revenue in the first quarter of 2018.
TerrAscend's adjusted EBITDA loss of CA$7.2 million is higher than its CA$7.1-million loss in the prior quarter and its CA$1.6-million loss in the same period in 2018.
The net first-quarter loss of CA 26 cents per share is wider than the CA 2-cent loss per share a year earlier.
The company ended March with CA$8.6 million in cash and cash equivalents.
Why It's Important
TerrAscend has scaled operations in both Canada and the U.S. During the first quarter, the company said it posted CA$5.7 million in sales of hemp-derived CBD products in the U.S.
In February, TerrAscend announced the establishment of an American retail footprint through the acquisition of Apothecarium, a multistate dispensary operator with locations in California and Nevada.
The acquisition also includes Valhalla Confections, a manufacturer of edible products.
TerrAscend is in the process of completing the acquisition of Apothecarium.
The company expects to start distribution of products in Germany after having received a GMP certificate for its Mississauga, Ontario facility.
TerrAscend said it expects full-year revenue of more than CA$135 million.
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.